| CAS Number | 921769-65-5 |
| Catalog Number | AG00GY00(AGN-PC-0VYJ0B) |
| Chemical Name | Capecitabine-2',3'-cyclic carbonate |
| IUPAC Name | pentyl N-[1-[(3aS,4R,6R)-6-methyl-2-oxo-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate |
| InChI | InChI=1S/C16H20FN3O7/c1-3-4-5-6-24-15(22)19-12-9(17)7-20(14(21)18-12)13-11-10(8(2)25-13)26-16(23)27-11/h7-8,10-11,13H,3-6H2,1-2H3,(H,18,19,21,22)/t8-,10?,11+,13-/m1/s1 |
| InChI Key | VTAMAYSBXXKQPB-IZSYJUOESA-N |
| MDL Number | MFCD23160273 |
| Molecular Formula | C16H20FN3O7 |
| Molecular Weight | 385.3443 |
| SMILES | CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@@H](C2[C@@H]1OC(=O)O2)C |
| Synonyms | Capecitabine-2',3'-cyclic Carbonate,
921769-65-5,
CTK8E7881,
AKOS030254715,
RT-011910,
FT-0664230,
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine Cyclic 2',3'-Carbonate,
UNII-98DRJ1XQ80,
Capecitabine related compound C,
Capecitabine related compound C [USP],
Capecitabine-2',3'-cyclic carbonate, 98.5% - 10MG 10mg,
2',3'-O-Carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine,
Cytidine, 5'-deoxy-5-fluoro-N-((pentyloxy)carbonyl)-, cyclic 2',3'-carbonate,
|
| Complexity | 696 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 385.129g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 27 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 385.348g/mol |
| Monoisotopic Mass | 385.129g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 116A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2 |
GHS Hazard and Precautionary Statements
| Symbol: | |
|
Hazard statements
|
|
|
Precautionary statements
|
|
Certificate of Analysis
Lot Number